DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Imgatuzumab
Imgatuzumab
Strategies to Enhance Monoclonal Antibody Uptake and Distribution in Solid Tumors
Deciphering Molecular Mechanisms and Prioritizing Therapeutic Targets in Cardio-Oncology
Valstybinės Vaistų Kontrolės Tarnybos Prie Lietuvos Respublikos Sveikatos Apsaugos Ministerijos Viršininko Į S a K Y M a S
The Two Tontti Tudiul Lui Hi Ha Unit
ADCC Responses and Blocking of EGFR-Mediated Signaling and Cell Growth by Combining the Anti-EGFR Antibodies Imgatuzumab and Cetuximab in NSCLC Cells
(INN) for Biological and Biotechnological Substances
Harnessing Integrative Omics to Facilitate Molecular Imaging of the Human Epidermal Growth Factor Receptor Family for Precision Medicine Martin Pool1*, H
CHAPTER 3 Extracellular Domain Shedding Influences Specific Tumor Uptake and Organ Distribution of the EGFR PET Tracer 89Zr-Imgatuzumab
Clinical Development of Molecular Targeted Therapy in Head and Neck Squamous Cell Carcinoma Paul Gougis , Camille Moreau Bachelard, Maud Kamal, Hui K
Stembook 2018.Pdf
A Abacavir Abacavirum Abakaviiri Abagovomab Abagovomabum
(12) Patent Application Publication (10) Pub. No.: US 2017/0203043 A1 Rusch Et Al
(12) Patent Application Publication (10) Pub. No.: US 2016/0184445 A1 Perroth Et Al
(INN) for Biological and Biotechnological Substances
Utilizing Immunopet to Measure Tumor Response to Treatment in Breast Cancer
The Effects of Flow on Therapeutic Protein Aggregation
Clinical Development of Molecular Targeted Therapy in Head and Neck Squamous Cell Carcinoma Paul Gougis , Camille Moreau Bachelard, Maud Kamal, Hui K
N° 18380 A61k 31/5377 (2018.01) A61p 35/02 (2018.01)
Top View
(12) Patent Application Publication (10) Pub. No.: US 2016/0177276 A1 L0 Et Al
6.6.2018 a Abacavir Abacavirum Abakaviiri Abagovomab
International Nonproprietary Names (INN) for Biological and Biotechnological Substances
Mai Muita in Acut Ca Uti on Muunni
Riport Letöltése
One for Treatment of Solid Cancers
Extracellular Domain Shedding Influences Specific Tumor Uptake and Organ Distribution of the EGFR PET Tracer 89Zr-Imgatuzumab
Download1 MB
(12) Patent Application Publication (10) Pub. No.: US 2017/0173267 A1 Ashmead Et Al
The Latest Battles Between EGFR Monoclonal Antibodies and Resistant Tumor Cells
PET Imaging of Receptor Tyrosine Kinases in Cancer Weijun Wei1,2,Dalongni2, Emily B
Translational Insights and New Therapeutic Perspectives in Head and Neck Tumors
International Nonproprietary Names for Pharmaceutical Substances (INN)
(2006.01) C07d 413/14
( 12 ) Patent Application Publication
WO 2016/001485 Al 7 January 2016 (07.01.2016) P O P C T
Looking for Therapeutic Antibodies in Next Generation Sequencing Repositories
Dermatologic Toxicity Occurring During Anti-EGFR Monoclonal Inhibitor Therapy in Patients with Metastatic Colorectal Cancer: a Systematic Review Mario E